CAS: 20532-33-6; 5-Chlorobenzothiophene

该化合物是一种环环状的杂交芳香化合物,其特点是存在一个硫苯环,并附着在苯环上,在硫苯的5个位置上有一个氯替代体.该化合物通常表现出黄色到浅棕色的青色外观,以其在水中的溶解性相对较低而闻名,同时在有机溶剂中更易溶解.它有独特的芳香味,在标准条件下保持稳定.氯原子的存在具有独特的电子特性,影响其再活性和在有机合成和材料科学中的潜在应用.5-Chlorobenzo[b]thiophene经常用于制药,农用化学品和合成更复杂的有机分子的建筑块块.其化学行为可能受到氯原子的含电阻性质的影响,这可能影响其在电子哲学替代反应中的再活性.在处理这一化合物时,应当采取安全防范措施,因为如果在物理或化学替代中,可能会对健康构成风险.

结构式图片

上下游产品

CAS号50548-46-4 1-Chloro-4-[(2,... | CAS号118743-10-5 (4-chlorophenyl... | CAS号13771-75-0 5-氯-1-苯并噻吩-2-羧酸 | CAS号106-54-7 4-氯苯硫酚 | CAS号110-81-6 二乙基二硫 | CAS号106-46-7 1,4-二氯苯 | CAS号32969-26-9 3-溴-5-氯苯并[b]噻吩 | CAS号20532-30-3 5-甲氧基苯并噻吩 | CAS号20532-28-9 5-氨基苯并噻吩 | CAS号2060-63-1 1-苯并噻吩-5-腈 | CAS号28540-51-4 5-氯苯并[b]噻吩-2-羧醛 | CAS号2060-64-2 1-苯并噻吩-5-羧酸 | CAS号128851-98-9 5-Chlorobenzo[b... | CAS号13771-75-0 5-氯-1-苯并噻吩-2-羧酸

合成工艺路线路线简述

    5-氯-1-苯并噻吩-2-羧酸置于喹啉,铜体系中,化学反应 0.5H,以18%的收率获得5-氯苯并噻吩
    参考文献:新的5-取代的苯并[ B ]噻吩衍生物的合成
    标题:新的5-取代的苯并[ B ]噻吩衍生物的合成
    摘要:我们小组以前的工作涉及1-(芳基)-3-[4-(芳基)哌嗪-1-基]丙烷衍生物的合成,以寻找具有双重作用方式的新型高效抗抑郁药:5-羟色胺再摄取抑制和5-Ht 1A受体的亲和力[1-4].从这些研究中我们得出结论,3-[4-(芳基)哌嗪-1-基]-1-(苯并[ B ]噻吩-3-基)丙烷衍生物导致了最佳结果.该研究项目的继续,需要制备一些新的3-酰基-5-取代的苯并[ B ]噻吩,其在5位上具有广泛的取代基,范围从硝基到羟基衍生物.为了获得这些衍生物,我们尽可能地将相应的5-取代的苯并[ B ]噻吩酰化.
    Doi:10.1002/jhet.5570380502

    海关参考信息

    专利信息


    专利号:WO-9427985-A1
    优先权日:1993-05-28
    标题 :Process for the preparation of substituted 3-halomethyl-benzothiophenes, benzofurans and -indoles and intermediates thereof
    发明人:PRIDGEN LENDON NORWOOD
    权利人:SMITHKLINE BEECHAM CORP; PRIDGEN LENDON NORWOOD
    摘要:This invention relates to novel intermediates and processes for preparing useful intermediates of formula (I) which are useful in the synthesis of pharmaceutically active agents.

    专利号:US-2005192265-A1
    优先权日:2003-03-20
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:WO-9967219-A1
    优先权日:1998-06-22
    标 题:Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
    发明人:AUDIA JAMES E; PORTER WARREN J; THOMPSON RICHARD C; WILKIE STEPHEN C; STACK DOUGLAS R; SHI QING
    权利人:ELAN PHARM INC; LILLY CO ELI; AUDIA JAMES E; PORTER WARREN J; THOMPSON RICHARD C; WILKIE STEPHEN C; STACK DOUGLAS R; SHI QING
    摘要:Compounds of formula (I), wherein W is a cyclic group of the type (2); (3); Y is represented by the formula (II); these compounds inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:WO-9966934-A1
    优先权日:1998-06-22
    标 题 :CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
    发明人:AUDIA JAMES E; DRESSMAN BRUCE A; SHI QING
    权利人:ELAN PHARM INC; LILLY CO ELI; AUDIA JAMES E; DRESSMAN BRUCE A; SHI QING
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-6774125-B2
    优先权日:1998-06-22
    标 题:Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:AUDIA JAMES E; THOMPSON RICHARD C; WILKIE STEPHEN C; BRITTON THOMAS C; PORTER WARREN J; HUFFMAN GEORGE W; LATIMER LEE H
    权利人:ELAN PHARM INC; LILLY CO ELI
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-6509331-B1
    优先权日:1998-06-22
    标题:Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:AUDIA JAMES E; THOMPSON RICHARD C; WILKIE STEPHEN C; BRITTON THOMAS C; PORTER WARREN J; HUFFMAN GEORGE W; LATIMER LEE H
    权利人:ELAN PHARM INC; LILLY CO ELI
    摘要:Disclosed are compounds which inhibit beta-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits beta-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
    杭州优联医药化工公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.unipharma-chem.com
    企业联系电话:0571-85803833;56766020👤
    📞杭州优联医药化工公司 ⚠️参考联系方式
    联系人:顾元伟
    电话:0571-85803833;56766020

    传真:0571-85803855
    邮箱:info@unipharma-chem.com
    通信地址: 浙江省杭州市朝晖路203号深蓝广场办公楼1109室
    邮编: 310010
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省杭州市朝晖路203号深蓝广场办公楼1109室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Yoshikai, N.; Rayner, C. M.; Graham, M. A., Science of Synthesis Knowledge Updates, (2020) 2, 94.
    摘要:Huang, J.; Ma, D., Science of Synthesis: Special Topics, (2022) 1, 12.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知